FTV vs PPCB · P/E 31, rev $6.23B vs P/E 0.0, $3.9M cap
Fortive Corp (FTV) versus Propanc Biopharma, Inc. Common Stock (PPCB) — a side-by-side from cached financials, not a winner call.
Fortive Corp (FTV) is a scientific & technical instruments company listed on US.
Propanc Biopharma, Inc. Common Stock (PPCB) is a biotechnology company listed on NASDAQ.
Latest reported FTV revenue for 2024-12-31 was $6.23B. Net income was $832.9M. Revenue was up 2.7% from 2023-12-31 to 2024-12-31. FTV currently screens at market cap $24.34B and trailing P/E 31.4.
PPCB does not have a complete income-statement cache yet.
FTV currently screens at market cap $24.34B and trailing P/E 31.4. PPCB currently screens at market cap $3.9M and trailing P/E 0.0.
Not investment advice. Open the FTV and PPCB stock pages for the full models.
Not investment advice.